Document is current

Any future updates will be listed below

Correction to: Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021–2023

Crossref DOI link: https://doi.org/10.1007/s12325-024-03087-2

Published Online: 2025-01-06

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark